Baird analyst David Rescott lowered the firm’s price target on Intuitive Surgical (ISRG) to $575 from $600 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results as tariff impacts were roughly inlie with expectations and the company seeing likely offset levers.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical: Strong Performance and Growth Potential Amidst Challenges
- Intuitive Surgical Reports Strong Q1 2025 Earnings
- Closing Bell Movers: Tesla jumps on Musk plans to pare back his DOGE work
- Intuitive Surgical sees FY25 capital expenditures $650M-$750M
- ISRG Earnings: Intuitive Surgical’s Financial Results Top Wall Street Estimates